CAMSON BIO TECHNOLOGIES LTD.

NSE : NABSE : 538858ISIN CODE : INE845E01012Industry : AgricultureHouse : Private
BSE3.310 (0 %)
PREV CLOSE ( ) 3.31
OPEN PRICE ( ) 3.31
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1760
TODAY'S LOW / HIGH ( )3.31 3.31
52 WK LOW / HIGH ( ) 3.313.31
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2018Mar2017Mar2016Mar2015Mar2014
Profit Before Tax-112.17-273.74-435.1020.91126.90
Adjustment109.87221.48295.86267.05172.17
Changes In working Capital57.2498.40-43.33-108.48-468.56
Cash Flow after changes in Working Capital54.9346.14-182.58179.48-169.48
Cash Flow from Operating Activities54.9345.62-188.92189.69-163.70
Cash Flow from Investing Activities-34.1427.21118.83-542.01-345.90
Cash Flow from Financing Activities-20.50-73.2566.63347.32512.28
Net Cash Inflow / Outflow0.28-0.42-3.46-5.002.68
Opening Cash & Cash Equivalents0.621.056.0619.5616.88
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent0.910.622.6014.5619.56

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.